Cite
VEGFR targeting leads to significantly enhanced tumor uptake of nanographene oxide in vivo.
MLA
Shi, Sixiang, et al. “VEGFR Targeting Leads to Significantly Enhanced Tumor Uptake of Nanographene Oxide in Vivo.” Biomaterials, vol. 39, Jan. 2015, pp. 39–46. EBSCOhost, https://doi.org/10.1016/j.biomaterials.2014.10.061.
APA
Shi, S., Yang, K., Hong, H., Chen, F., Valdovinos, H. F., Goel, S., Barnhart, T. E., Liu, Z., & Cai, W. (2015). VEGFR targeting leads to significantly enhanced tumor uptake of nanographene oxide in vivo. Biomaterials, 39, 39–46. https://doi.org/10.1016/j.biomaterials.2014.10.061
Chicago
Shi, Sixiang, Kai Yang, Hao Hong, Feng Chen, Hector F. Valdovinos, Shreya Goel, Todd E. Barnhart, Zhuang Liu, and Weibo Cai. 2015. “VEGFR Targeting Leads to Significantly Enhanced Tumor Uptake of Nanographene Oxide in Vivo.” Biomaterials 39 (January): 39–46. doi:10.1016/j.biomaterials.2014.10.061.